Abstract
Microsatellite and KRAS status affect the development of colorectal carcinoma (CRC) and can warrant specific clinical management. This study assesses current trends and outcomes of testing for microsatellite and KRAS status in stage IV CRC patients in the US.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have